about
TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesionsImaging genome abnormalities in cancer researchChromosomal aberrations in lymphocytes of healthy subjects and risk of cancer.Translating cancer genomes and transcriptomes for precision oncologyPatterns of Chromosomal Aberrations in Solid TumorsFusionSeq: a modular framework for finding gene fusions by analyzing Paired-End RNA-Sequencing dataEvolutionary constraint and disease associations of post-translational modification sites in human genomesUnderstanding spatial organizations of chromosomes via statistical analysis of Hi-C dataPooled analysis of loss of heterozygosity in breast cancer: a genome scan provides comparative evidence for multiple tumor suppressors and identifies novel candidate regions.Extracting consistent knowledge from highly inconsistent cancer gene data sources.ToP: a trend-of-disease-progression procedure works well for identifying cancer genes from multi-state cohort gene expression data for human colorectal cancer.Telomere disruption results in non-random formation of de novo dicentric chromosomes involving acrocentric human chromosomes.The mutator phenotype in cancer: molecular mechanisms and targeting strategiesA Boolean-based systems biology approach to predict novel genes associated with cancer: Application to colorectal cancer.Gene expression identifies heterogeneity of metastatic behavior among high-grade non-translocation associated soft tissue sarcomas.Detecting copy number status and uncovering subclonal markers in heterogeneous tumor biopsies.Delayed replication timing leads to delayed mitotic chromosome condensation and chromosomal instability of chromosome translocations.New therapeutic targets in soft tissue sarcoma.Absolute quantification of somatic DNA alterations in human cancerThe utility of t(14;18) in understanding risk factors for non-Hodgkin lymphoma.Systematic analysis of somatic mutations in phosphorylation signaling predicts novel cancer driversSKY analysis revealed recurrent numerical and structural chromosome changes in BDII rat endometrial carcinomas.High level of chromosomal aberration in ovarian cancer genome correlates with poor clinical outcomeFluorescence in situ hybridization is necessary to detect an association between chromosome aberrations and polycyclic aromatic hydrocarbon exposure in utero and reveals nonrandom chromosome involvement.CancerGenes: a gene selection resource for cancer genome projects.The EML4-ALK oncogene: targeting an essential growth driver in human cancer.Spatial genome organization in the formation of chromosomal translocationsGenetic and biological subgroups of low-stage follicular thyroid cancerHigh variability of genomic instability and gene expression profiling in different HeLa clones.CLImAT-HET: detecting subclonal copy number alterations and loss of heterozygosity in heterogeneous tumor samples from whole-genome sequencing data.Landscape of gene fusions in epithelial cancers: seq and ye shall find.Microhomology directs diverse DNA break repair pathways and chromosomal translocations.Chromosomal analysis of non-small-cell lung cancer by multicolour fluorescent in situ hybridisationArray painting reveals a high frequency of balanced translocations in breast cancer cell lines that break in cancer-relevant genes.Aneuploidy in health, disease, and aging.Pleiotropic biological activities of alternatively spliced TMPRSS2/ERG fusion gene transcripts.Recurrent gene fusions in prostate cancerThe mutational landscape of phosphorylation signaling in cancer.Genomic variation within alpha satellite DNA influences centromere location on human chromosomes with metastable epialleles.Genome based cell population heterogeneity promotes tumorigenicity: the evolutionary mechanism of cancer
P2860
Q24678489-7BFF1437-4D14-45A2-A02E-F3CBF4798FC2Q24794612-59A53F56-715E-4366-BFA3-C26A839F12A1Q24812783-ED8E4301-23E6-42DB-B1A0-1A7065935C7DQ26777081-EB0F0B6C-0C06-4FAB-B7EA-B3C3C69B6A24Q26786127-668404EF-B92B-46E3-AE79-72D4E02D41DBQ27499410-E81E2D2E-171C-44BB-9B93-463472C74399Q28543059-A09B17EF-00FE-4443-AC5A-B660210BD3ADQ28647858-B4430C7B-71E8-4922-A550-F29A5C10373EQ30476046-8934633B-D5B6-405D-88B8-5A6D774C8C27Q30493496-9CCE8B74-0846-4F79-8B4F-A779D7F99C97Q30651525-934DC03B-8342-4A92-84C5-B99C06AC1F93Q33658678-1504C166-F9EA-4617-9145-7BB5D8AFA92CQ33815796-70C3A082-3FFB-4ECC-BA34-2AD4249BFA61Q33830172-B6DC4F9C-664B-433E-BFCD-15FCA9047C93Q33847814-479B7154-CF7D-4BEF-990E-9BC52610B604Q33898708-0F5E2D57-5FDD-4DD4-8130-B789C994418BQ33949329-C54D94D5-6118-4D55-8FCE-7E78205FFC50Q34267924-AEE62241-BC2A-4CCF-B699-1F4673199189Q34271693-71D368C5-D7C1-43AE-8851-35EEC8243979Q34273273-A9761680-FC5F-4E6F-844F-675351FE00B2Q34323801-11D57C8F-83F8-4F74-A435-065230C6B3BFQ35136112-8C36AAA9-80F7-4654-AF7A-B946DCC91DE6Q35190585-8C1E15C4-88A5-4409-9140-7408CB2105A9Q35596335-59FDCFA3-7F6B-496B-9821-979EBC6B69B4Q35608470-159CDE1D-4CE9-4231-82A9-DF46C3CDFBF6Q35631006-DF9AE6F0-55AA-47C4-ADAE-A0B316BF2314Q35650635-C339D389-71E1-4E2E-A552-EAD0252B1EDCQ35749248-BCA01584-0440-4787-97F9-C618F5B7B3ABQ36184351-BDFA65A9-821A-4E9C-A1AC-83AC0D963E90Q36309643-400FDF25-295C-46CF-B24F-1B4B1A4D49A3Q36383369-206530C9-EDD4-4C10-BEBE-9D0E63308543Q36384380-F8C7E3AF-4161-4F20-87C0-62D1D75950ADQ36696688-EC35A5C0-0834-402A-BBEE-766525C1FA26Q36710467-23B3B32B-3A7A-48B4-9FF4-8B8357C85428Q36732750-43CBEF67-5726-42C4-BC6D-9CDB3ABE5667Q37003441-F100B059-337F-4D36-90E9-35E4B4DE0BBBQ37194503-4615A89E-0FF2-4B7E-8AC7-BE502B925B11Q37210868-99DD831F-DCB8-42FD-AF78-15F5A72E97AEQ37313724-E029C674-67A8-4F75-9D2C-A284C7D1C6D5Q37422915-D631F6CF-B894-4392-B929-5005FAE665E6
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Recurrent chromosome aberrations in cancer.
@ast
Recurrent chromosome aberrations in cancer.
@en
type
label
Recurrent chromosome aberrations in cancer.
@ast
Recurrent chromosome aberrations in cancer.
@en
prefLabel
Recurrent chromosome aberrations in cancer.
@ast
Recurrent chromosome aberrations in cancer.
@en
P1433
P1476
Recurrent chromosome aberrations in cancer.
@en
P2093
Mitelman F
P304
P407
P577
2000-04-01T00:00:00Z